/New Guidelines Push for Early Detection of Liver Disease Among High-Risk Groups
– New national guidelines advocate for earlier assessment of liver disease, targeting millions at risk.
– All individuals diagnosed with type 2 diabetes should undergo testing for advanced liver disease.
– The guidelines emphasize proactive measures for early identification, reducing the chances of severe complications.
– Experts warn of the “silent” nature of liver disease, often leading to late diagnoses.
– Increased awareness and education are necessary for both healthcare professionals and the public.
Significant changes to the approach towards liver disease identification in the UK have been introduced with the latest guidelines from the British Society of Gastroenterology. Published in the journal Gut, the guidelines recommend earlier testing for individuals at increased risk, including the first-time inclusion of everyone diagnosed with type 2 diabetes.
The guidelines highlight the importance of detecting liver disease at an early stage, emphasizing that timely intervention can prevent severe complications and, in many instances, halt or reverse liver damage. Liver disease is often termed a “silent” condition due to the lack of symptoms until significant damage has occurred, resulting in many individuals receiving a diagnosis only when they are in advanced stages like cirrhosis or liver cancer.
A key modification in the new guidelines is the recommendation that all individuals with type 2 diabetes be assessed for advanced liver disease. Given that these patients are at a considerably higher risk, many remain unaware of the potential dangers and often do not receive necessary assessments. The guidelines propose initial testing upon diagnosis, followed by repeated assessments every five years in the absence of advanced disease.
In addition to assessing individuals with diabetes, the guidelines urge proactive testing for those consuming harmful amounts of alcohol, enhanced follow-up for abnormal liver blood tests, evaluations when liver disease is incidentally detected in scans, and greater utilization of simple, non-invasive tests to identify liver scarring before symptoms emerge.
Professor Stuart McPherson, Consultant Hepatologist and lead author of the guidelines, stated, “Most serious liver disease develops over many years. The challenge is that patients often feel perfectly well until significant scarring has occurred. These guidelines bring together the latest evidence and provide a practical framework to help healthcare professionals identify people at highest risk and ensure they receive the right investigations and specialist care when needed.”
Vanessa Hebditch, Director of Communications and Policy at Liver UK and a member of the guideline development group, emphasized the transformative potential of these guidelines: “These guidelines mark a major step forward in the early detection of liver disease. For too long, liver disease has often been diagnosed when it is already advanced and much harder to treat. Yet the reality is that liver disease can develop silently over many years, often without causing any symptoms.”
She added, “The new recommendations recognize that we need to be much better at identifying people at risk and offering them simple tests before irreversible damage occurs.”
The guidelines suggest a two-step approach that employs simple blood tests and non-invasive fibrosis tests, including the FIB-4 blood test score and, when necessary, additional assessments such as the ELF blood test or a non-invasive liver scan known as transient elastography.
Personal accounts from individuals affected by liver disease underscore the need for these updated guidelines. Sara shared the story of her father, Stephen, who had lived with type 2 diabetes since 2000. After abnormal liver function tests in 2014, he was not referred for follow-up assessment and, tragically, was diagnosed with MASLD and cirrhosis in 2024, passing away shortly thereafter. Sara remarked, “People living with type 2 diabetes should know that they can also be at risk of liver disease.”
Similarly, Michelle reflected on her own experience, revealing that despite her diagnosis of type 2 diabetes and subsequent cirrhosis, she had no prior knowledge of the risk of liver disease. “It was only in 2021 when I was having some routine blood tests for my diabetes that my liver enzymes showed signs of concern,” she said.
The guidelines aim to combat the low awareness of liver disease among primary care professionals. Liver UK has developed a practical guide for GPs to aid in the early identification and referral of at-risk individuals. Furthermore, new online resources are available for the public, detailing who should be tested for liver disease and what to expect during the testing process.
Research indicates that a significant number of liver disease-related fatalities are preventable through early diagnosis and intervention. Experts are hopeful that these new recommendations will lead to more individuals being diagnosed before the progression of liver disease and its associated complications.
